Marshall Wace’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $85.5K | Sell |
22,100
-1,146,238
| -98% | -$4.44M | ﹤0.01% | 2415 |
|
|
2025
Q1 | $5.84M | Buy |
1,168,338
+1,102,821
| +1,683% | +$5.51M | 0.01% | 920 |
|
|
2024
Q4 | $472K | Buy |
+65,517
| New | +$472K | ﹤0.01% | 1913 |
|
|
2024
Q1 | – | Sell |
-86,132
| Closed | -$969K | – | 2091 |
|
|
2023
Q4 | $969K | Sell |
86,132
-1,712,608
| -95% | -$19.3M | ﹤0.01% | 1230 |
|
|
2023
Q3 | $4.68M | Sell |
1,798,740
-260,550
| -13% | -$677K | 0.01% | 794 |
|
|
2023
Q2 | $7.27M | Buy |
2,059,290
+462,160
| +29% | +$1.63M | 0.01% | 758 |
|
|
2023
Q1 | $6.74M | Buy |
1,597,130
+357,336
| +29% | +$1.51M | 0.01% | 735 |
|
|
2022
Q4 | $20.4M | Buy |
1,239,794
+140,880
| +13% | +$2.32M | 0.05% | 389 |
|
|
2022
Q3 | $14M | Buy |
1,098,914
+828,584
| +307% | +$10.6M | 0.03% | 566 |
|
|
2022
Q2 | $3.16M | Buy |
+270,330
| New | +$3.16M | 0.01% | 1402 |
|
|
2021
Q4 | – | Sell |
-478,923
| Closed | -$5.42M | – | 3120 |
|
|
2021
Q3 | $5.42M | Sell |
478,923
-449,793
| -48% | -$5.09M | 0.02% | 787 |
|
|
2021
Q2 | $9.15M | Buy |
+928,716
| New | +$9.15M | 0.04% | 465 |
|
|
2021
Q1 | – | Sell |
-31,049
| Closed | -$350K | – | 2080 |
|
|
2020
Q4 | $350K | Buy |
+31,049
| New | +$350K | ﹤0.01% | 1477 |
|